Secreted and membrane-bound mucins and idiopathic peptic ulcer disease

Digestion

Volumn 86, Issue 3, 2012, Pages 258-263

  Niv, Yaron ^a   Boltin, Doron ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Aspirin; Helicobacter pylori; Mucin; Peptic ulcer

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; STOMACH MUCIN;

HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; NONHUMAN; PEPTIC ULCER; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; ULCEROGENESIS;

GASTRIC MUCOSA; HUMANS; INCIDENCE; MUCINS; PEPTIC ULCER; WORLD HEALTH;

EID: 84867464392     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000341423     Document Type: Review

References (38)

1. Malfertheiner P, Chan FKL, McColl KEL: Peptic ulcer disease. Lancet 2009; 374: 1449-1461.
2. McColl KEL: How I manage H. pylori-negative, NSAID/aspirin-negative peptic ulcers. Am J Gastroenterol 2009; 104: 190-193.
3. Jyotheeswaran S, Shah AN, Jin HO, Potter GD, Ona FV, Chey WY: Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, N.Y.: is empirical triple therapy justified? Am J Gastroenterol 1998; 93: 574-578.
4. Yakoob J, Jafri W, Jafri N, Islam M, Abid S, Hamid S, Alishah H, Shaikh H: Prevalence of non-Helicobacter pylori duodenal ulcer in Karachi, Pakistan. World J Gastroenterol 2005; 11: 3562-3565.
5. Ciociola AA, McSorley DJ, Turner K, Sykes D, Palman JB: Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated. Am J Gastroenterol 1999; 94: 1834-1840.
6. Chan HL, Wu JC, Chan FK, Choi CL, Ching JY, Lec YT, Leung WK, Lau JY, Ching SC, Sung JJ: Is non-Helicobacter pylori , non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patients. Gastrointest Endosc 2001; 53: 438-442.
7. Arroyo MT, Forne M, de Argila CM, Feu F, Arenas J, de la Vega J, Ganigues V, Mora F, Castro M, Bujanda L, Cosme A, Castiella A, Gisbert JP, Hervas A: The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in Southern Europe. Helicobacter 2004; 9: 249-254.
8. Nishikawa K, Sugiyama T, Kato M, Ishizuka J, Komatsu Y, Kagaya H, Katagiri M, Nishikawa S, Hakari K, Takeda H, Asaka M: Non-Helicobacter pylori and non-NSAID peptic ulcer disease in the Japanese population. Eur J Gastroenterol Hepatol 2000; 12: 635-640.
9. Gisbert JP, Blanco M, Mateos JM, Fernandez-Salazar L, Fernandez-Bermejo M, Cantero J, Pajares JM: H. pylori-negative duodenal ulcer prevalence and causes in 774 patients. Dig Dis Sci 1999; 44: 2295-2302.
10. Xia HHX, Wong BCY, Wong KW: Clinical and endoscopic characteristics of non-Helicobacter pylori , non-NSAID duodenal ulcers: a long-term prospective study. Aliment Pharmacol Ther 2001; 15: 1875-1882.
11. Jensen PH, Kolarich D, Packer NH: Mucintype O-glycosylation-putting the pieces together. FEBS J 2010; 277: 81-94.
12. Kim YS, Ho SB: Intestinal goblet cells and mucins in health and disease: recent insights and progress. Curr Gastroenterol Rep 2010; 12: 319-330.
13. Hattrup CL, Gendler SJ: Structure and function of the cell surface (tethered) mucins. Annu Rev Physiol 2008; 70: 431-457.
14. Phillipson M, Johansson ME, Henriksnäs J, Petersson J, Gendler SJ, Sandler S, Persson AE, Hansson GC, Holm L: The gastric mucus layers: constituents and regulation of accumulation. Am J Physiol Gastrointest Liver Physiol 2008; 295:G806-G812.
15. Morgenstern S, Koren R, Fraser G, Okon E, Niv Y: Gastric corpus mucin expression after partial gastrectomy, in relation to colonization with Helicobacter pylori . J Clin Gastroenterol 2001; 32: 218-221.
16. Morgenstern S, Koren R, Moss SF, Fraser G, Okon E, Niv Y: Does Helicobacter pylori affect gastric mucin expression? Relationship between gastric antral mucin expression and H. pylori colonization. Eur J Gastroenterol Hepatol 2001; 13: 19-23.
17. Ho SB, Takamura K, Anway R, Shekels LL, Toribara NW, Ota H: The adherent gastric mucous layer is composed of alternating layers of MUC5AC and MUC6 mucin proteins. Dig Dis Sci 2004; 49: 1598-1606.
18. Tanaka S, Mizuno M, Maga T, Yoshinoga F, Tomada J, Nasu J, Okada H, Yokota K, Oguma K, Shiratori Y, Tsuji T: H. pylori decreases gastric mucin synthesis via inhibition of galactosyltransferase. Hepatogastroenterology 2003; 50: 1739-1742.
19. Byrd JC, Yunker CK, Xu QS, Sternberg LR, Bresalier RS: Inhibition of gastric mucin synthesis by Helicobacter pylori . Gastroenterology 2000; 118: 1072-1079.
20. Kawakubo M, Ito Y, Okimura Y, Kobayashi M, Sakura K, Kasama S, Fukuda MN, Fukuda M, Katsuyama T, Nakayama Y: Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection. Science 2004; 305: 1003-1006.
21. Celli JP, Turner BS, Afdhal NH, Keates S, Ghiran I, Kelly CP, Ewoldt RH, Mekinley GH, So P, Erramilli S, Bansil R: Helicobacter pylori moves through mucus by reducing mucin viscoelasticity. Proc Natl Acad Sci USA 2009; 106: 14321-14326.
22. Kobayashi M, Lee H, Nakayama J, Fukuda M: Roles of gastric mucin-type O-glycans in the pathogenesis of Helicobacter pylori infection. Glycobiology 2009; 19: 453-461.
23. McGuckin MA, Lindén SK, Sutton P, Florin TH: Mucin dynamics and enteric pathogens. Nat Rev Microbiol 2011; 9: 265-278.
24. Andrianifahanana M, Moniaux N, Batra SK: Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases. Biochim Biophys Acta 2006; 1765: 189-222.
25. Rousseau K, Byrne C, Griesinger G, Leung A, Hill AS, Swallow DM: Allelic association and recombination hotspots in the mucin gene ( MUC ) complex on chromosome 11p15.5. Ann Hum Genet 2007; 71: 561-569.
26. Vincent A, Perrais M, Desseyn JL, Aubert JP, Pigny P, Vanseuningen I: Epigenetic regulation (DNA methylation, histone modifications) of the11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells. Oncogene 2007; 26: 6566-6576.
27. Fujisawa T, Velichko S, Thai P, Hung LY, Huang F, Wu R: Regulation of airway MUC5AC expression by IL-1 and IL-17A; the NF-B paradigm. J Immunol 2009; 183: 6236-6243.
28. Wong GL, Wong VW, Chan Y, Ching JY, Au K, Hui AJ, Lai LH, Chow DK, Siu DK, Lui YN, Wu JC, To KF, Hung LC, Chan HL, Sung JJ, Chan FK: High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Gastroenterology 2009; 137: 525-531.
29. Gisbert JP, Calvet X: Helicobacter pylori-negative duodenal ulcer disease. Aliment Pharmacol Ther 2009; 30: 791-815.
30. Bank S, Blumstein M, Greenberg RE, Magier D, Lavin PT: Efficacy of famotidine in the healing of active benign gastric ulceration: comparison of nonsteroidal anti-inflammatory-or aspirin-induced gastric ulcer and idiopathic gastric ulceration. Long Island Jewish Medical Center Acid-Peptic Study Group. Clin Ther 1993; 15: 36-45.
31. Xia HH, Phung N, Kalantar JS, Talley NJ: Demographic and endoscopic characteristics of patients with Helicobacter pylori positive and negative peptic ulcer disease. Med J Aust 2000; 173: 515-519.
32. Arents NL, Thijs JC, van Zwet AA, Kleibeuker JH: Does the declining prevalence of Helicobacter pylori unmask patients with idiopathic peptic ulcer disease? Trends over an 8-year period. Eur J Gastroenterol Hepatol 2004; 16: 779-783.
33. Chen TS, Chang FY: Clinical characteristics of Helicobacter pylori-negative duodenal ulcer disease. Hepatogastroenterology 2008; 55: 1615-1618.
34. Boltin D, Helpern M, Levi Z, Vilkin A, Morgenstern S, Ho SB, Niv Y: Gastric mucin expression in Helicobacter pylori , nonsteroidal anti-inflammatory drug and idiopathic ulcers. World J Gastroenterol 2012 (in press).
35. Sarosiek J, Mizuta K, Slomiany A, Slomiany BL: Effect of acetylsalicylic acid on gastric mucin viscosity, permeability to hydrogen ion and susceptibility to pepsin. Biochem Pharmacol 1986; 35: 4291-4295.
36. Ishihara K, Ichikawa T, Komuro Y, Ohara S, Hotta K: Effect on gastric mucus of the proton pump inhibitor leminoprazole and its cytoprotective action against ethanol-induced gastric injury in rats. Arzneimittelforschung 1994; 44: 827-830.
37. Skoczylas T, Sarosiek I, Sostarich S, McElhinney C, Durham S, Sarosiek J: Significant enhancement of gastric mucin content after rabeprazole administration: its potential clinical significance in acid-related disorders. Dig Dis Sci 2003; 48: 322-328.
38. Jaworski T, Sarosiek I, Sostarich S, Soesen K, Connor M, Brotze S, Wallner G, Sarosiek J: Restorative impact of rabeprazole on gastric mucus and mucin production impairment during naproxen administration: its potential clinical significance. Dig Dis Sci 2005; 50: 357-365.